,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,6,22.1,Retching,16885171
1,6,22.1,Hallucination,16885171
2,5,22.1,Death,16885171
3,6,22.1,Asthenia,16885171
4,6,22.1,Vomiting,16885171
0,5,22.1,Myelodysplastic syndrome,16885250
0,5,22.1,Infection,16885264
0,5,22.1,Metabolic acidosis,16885265
0,3,22.1,Rash,16885283
1,6,22.1,Impaired healing,16885283
2,6,22.1,Increased tendency to bruise,16885283
3,6,22.1,Pain in extremity,16885283
4,3,22.1,Nervous system disorder,16885283
5,6,22.1,Nightmare,16885283
6,6,22.1,Eye pruritus,16885283
7,3,22.1,Headache,16885283
8,6,22.1,Rhinorrhoea,16885283
9,6,22.1,Rash,16885283
10,1,22.1,Pruritus,16885283
11,6,22.1,Nail disorder,16885283
12,6,22.1,Epistaxis,16885283
13,6,22.1,Stomatitis,16885283
14,6,22.1,Eating disorder,16885283
15,6,22.1,Eye swelling,16885283
16,6,22.1,Headache,16885283
17,1,22.1,Dermatitis acneiform,16885283
18,3,22.1,Nail growth abnormal,16885283
19,6,22.1,Hair disorder,16885283
20,3,22.1,Skin disorder,16885283
21,3,22.1,Fatigue,16885283
22,6,22.1,Skin burning sensation,16885283
23,3,22.1,Rhinorrhoea,16885283
24,3,22.1,Onychomycosis,16885283
25,6,22.1,Oral mucosal blistering,16885283
26,6,22.1,Malignant neoplasm progression,16885283
27,6,22.1,Hypoaesthesia,16885283
28,6,22.1,Back pain,16885283
29,6,22.1,Stress,16885283
30,3,22.1,Onychoclasis,16885283
31,3,22.1,Pruritus,16885283
32,3,22.1,Acne,16885283
33,6,22.1,Hair growth abnormal,16885283
34,6,22.1,Depression,16885283
35,3,22.1,Urinary tract infection,16885283
36,3,22.1,Oropharyngeal pain,16885283
37,6,22.1,Poor quality sleep,16885283
38,6,22.1,Head discomfort,16885283
39,3,22.1,Rash papular,16885283
40,6,22.1,Dermatitis acneiform,16885283
41,6,22.1,Trichorrhexis,16885283
42,6,22.1,Vomiting,16885283
43,1,22.1,Acne,16885283
44,6,22.1,Drug ineffective,16885283
45,6,22.1,Pruritus,16885283
46,6,22.1,Diarrhoea,16885283
47,3,22.1,Onychalgia,16885283
48,6,22.1,Alopecia,16885283
49,2,22.1,Stomatitis,16885283
50,6,22.1,Ocular hyperaemia,16885283
51,6,22.1,Acne,16885283
52,6,22.1,Gastric neoplasm,16885283
0,6,22.1,Pancreatitis,16885308
1,6,22.1,Diarrhoea,16885308
2,6,22.1,Rheumatoid arthritis,16885308
3,6,22.1,Thyroid disorder,16885308
0,3,22.1,Fatigue,16885329
1,1,22.1,Mood swings,16885329
2,3,22.1,Nail ridging,16885329
3,1,22.1,Palpitations,16885329
4,6,22.1,Anxiety,16885329
5,1,22.1,Alopecia,16885329
6,1,22.1,Arthralgia,16885329
7,1,22.1,Vitamin D deficiency,16885329
8,2,22.1,Hot flush,16885329
9,2,22.1,Peripheral sensory neuropathy,16885329
10,1,22.1,Back pain,16885329
11,1,22.1,Diarrhoea,16885329
12,3,22.1,Musculoskeletal pain,16885329
0,5,22.1,Treatment failure,16885364
0,6,22.1,Drug resistance,16885404
1,6,22.1,Malignant neoplasm progression,16885404
0,3,22.1,Ovarian cancer metastatic,16885456
1,6,22.1,Neuropathy peripheral,16885456
2,6,22.1,Depression,16885456
3,1,22.1,Dizziness,16885456
4,1,22.1,Malignant ascites,16885456
5,6,22.1,Anxiety,16885456
6,6,22.1,Arthralgia,16885456
7,1,22.1,Dehydration,16885456
8,1,22.1,Ileus,16885456
9,6,22.1,Drug hypersensitivity,16885456
10,1,22.1,Anaemia,16885456
0,1,22.1,Skin toxicity,16885499
1,1,22.1,Pulmonary embolism,16885499
2,6,22.1,Ventricular dysfunction,16885499
3,6,22.1,Neutropenia,16885499
4,2,22.1,Performance status decreased,16885499
0,6,22.1,Device use error,16885612
1,6,22.1,Off label use,16885612
0,2,22.1,Pneumothorax,16885689
0,6,22.1,General physical health deterioration,16885734
0,2,22.1,Radiation pneumonitis,16885746
0,6,22.1,Neutropenia,16885785
1,6,22.1,Hypochromic anaemia,16885785
2,6,22.1,Skin discolouration,16885785
3,6,22.1,Mouth ulceration,16885785
0,1,22.1,Lung disorder,16885838
1,6,22.1,Off label use,16885838
2,1,22.1,Cerebral infarction,16885838
0,1,22.1,Muscular weakness,16885842
0,2,22.1,Bone marrow failure,16885845
0,1,22.1,Erythema multiforme,16885848
0,6,22.1,Tinea infection,16885850
1,6,22.1,Disease progression,16885850
2,6,22.1,Dry skin,16885850
3,6,22.1,Drug resistance,16885850
0,6,22.1,Off label use,16885854
1,1,22.1,Neutrophil count decreased,16885854
2,2,22.1,Dermatitis acneiform,16885854
0,3,22.1,Neutrophil count decreased,16885857
1,6,22.1,Off label use,16885857
0,3,22.1,Thyroiditis,16885859
0,5,22.1,Neoplasm progression,16885860
0,1,22.1,Febrile neutropenia,16885866
0,1,22.1,Pulmonary oedema,16885869
0,1,22.1,Radiation pneumonitis,16885907
0,1,22.1,Herpes zoster,16885915
0,5,22.1,Sepsis,16885923
0,5,22.1,Cerebrovascular accident,16885924
0,5,22.1,Death,16885925
0,5,22.1,Sepsis,16885926
0,5,22.1,Sepsis,16885927
0,5,22.1,Sepsis,16885929
0,5,22.1,Myocardial infarction,16885930
0,5,22.1,Death,16885931
0,5,22.1,Gastrointestinal haemorrhage,16885932
0,5,22.1,Sepsis,16885933
0,5,22.1,Ventricular fibrillation,16885934
0,5,22.1,Sepsis,16885935
0,5,22.1,Death,16885936
0,5,22.1,Respiratory failure,16885937
0,5,22.1,Sepsis,16885957
0,2,22.1,Interstitial lung disease,16886003
1,2,22.1,Diarrhoea,16886003
2,2,22.1,Gastroenteritis,16886003
3,2,22.1,Nasopharyngitis,16886003
4,2,22.1,Rhinorrhoea,16886003
5,2,22.1,Pyrexia,16886003
6,2,22.1,Arthralgia,16886003
7,2,22.1,Headache,16886003
0,3,22.1,Cerebrovascular accident,16886022
0,6,22.1,Cytopenia,16886032
1,5,22.1,Cardiopulmonary failure,16886032
2,5,22.1,Disease progression,16886032
0,6,22.1,Vomiting,16886068
1,6,22.1,Somnolence,16886068
2,6,22.1,Constipation,16886068
3,6,22.1,Nausea,16886068
4,6,22.1,Delirium,16886068
0,,22.1,Nausea,16886092
0,5,22.1,Death,16886111
0,5,22.1,Death,16886114
0,5,22.1,Death,16886130
0,6,22.1,Intentional product use issue,16886146
1,5,22.1,Disease progression,16886146
0,6,22.1,Pneumothorax,16886149
0,5,22.1,Pneumonia,16886154
0,5,22.1,Death,16886179
0,5,22.1,Pulmonary fibrosis,16886195
0,1,22.1,Atrial fibrillation,16886200
0,,22.1,Contusion,16886215
1,,22.1,Stomatitis,16886215
2,,22.1,Arthralgia,16886215
3,,22.1,Petechiae,16886215
0,,22.1,Disease progression,16886222
0,5,22.1,Transformation to acute myeloid leukaemia,16886223
0,6,22.1,Weight decreased,16886240
1,2,22.1,Gait inability,16886240
2,2,22.1,Abnormal loss of weight,16886240
3,3,22.1,Hypertension,16886240
4,2,22.1,Malaise,16886240
5,2,22.1,Feeding disorder,16886240
6,6,22.1,Asthenia,16886240
7,,22.1,Limb discomfort,16886240
8,1,22.1,Diarrhoea,16886240
9,6,22.1,Dysphonia,16886240
10,6,22.1,Dehydration,16886240
11,6,22.1,Blood pressure increased,16886240
12,2,22.1,Speech disorder,16886240
0,,22.1,Tumour flare,16886249
0,2,22.1,Neuropathy peripheral,16886297
1,1,22.1,Urticaria,16886297
2,6,22.1,Skin toxicity,16886297
0,3,22.1,Non-small cell lung cancer,16886300
0,5,22.1,Death,16886302
0,,22.1,Haematochezia,16886310
1,,22.1,Back pain,16886310
0,6,22.1,Nasopharyngitis,16886317
1,6,22.1,Malignant neoplasm progression,16886317
2,6,22.1,Ill-defined disorder,16886317
3,6,22.1,Pain,16886317
4,6,22.1,Drug resistance,16886317
0,6,22.1,Injection site induration,16886329
1,6,22.1,Injection site nodule,16886329
2,6,22.1,Haemangioma of liver,16886329
0,3,22.1,Dyspnoea,16886330
1,3,22.1,Oedema peripheral,16886330
0,,22.1,Disease progression,16886331
0,1,22.1,Vomiting,16886338
1,3,22.1,Decreased appetite,16886338
2,5,22.1,Malignant neoplasm progression,16886338
3,3,22.1,Product use complaint,16886338
4,6,22.1,Gastric disorder,16886338
5,6,22.1,Product size issue,16886338
0,5,22.1,Colorectal cancer metastatic,16886339
0,,22.1,Aphonia,16886346
1,,22.1,Deafness,16886346
0,,22.1,Death,16886377
0,6,22.1,Mental disorder,16886409
1,6,22.1,Fatigue,16886409
2,6,22.1,Performance status decreased,16886409
3,6,22.1,Vomiting,16886409
4,6,22.1,Nausea,16886409
5,6,22.1,Gait disturbance,16886409
6,3,22.1,Skin toxicity,16886409
7,6,22.1,Sepsis,16886409
8,3,22.1,Disease progression,16886409
0,6,22.1,Cerebrovascular accident,16886416
0,1,22.1,Bone marrow failure,16886424
0,6,22.1,Malignant neoplasm progression,16886433
1,6,22.1,Drug resistance,16886433
0,6,22.1,Biliary tract disorder,16886441
1,2,22.1,Liver disorder,16886441
2,3,22.1,Hypothyroidism,16886441
0,5,22.1,Malignant neoplasm progression,16886449
1,2,22.1,Pemphigoid,16886449
2,6,22.1,Drug ineffective,16886449
0,6,22.1,Acute respiratory failure,16886453
1,1,22.1,Pneumonia,16886453
0,6,22.1,Malignant neoplasm progression,16886464
0,2,22.1,Anaemia,16886494
1,2,22.1,Hypertransaminasaemia,16886494
0,6,22.1,Psychological trauma,16886563
1,2,22.1,Alopecia,16886563
0,6,22.1,Anxiety,16886565
1,6,22.1,Emotional distress,16886565
2,6,22.1,Impaired quality of life,16886565
3,6,22.1,Pain,16886565
4,3,22.1,Alopecia,16886565
0,6,22.1,Psychological trauma,16886573
1,2,22.1,Alopecia,16886573
0,1,22.1,Anal fistula,16886624
1,1,22.1,Anal fissure,16886624
0,6,22.1,Gilbert^s syndrome,16886671
0,6,22.1,Malignant neoplasm progression,16886691
0,6,22.1,Drug resistance,16886743
1,2,22.1,Headache,16886743
0,6,22.1,Drug resistance,16886744
1,6,22.1,Malignant neoplasm progression,16886744
0,,22.1,Intercepted product preparation error,16886779
1,,22.1,Wrong technique in product usage process,16886779
0,6,22.1,Extra dose administered,16886783
1,6,22.1,Product preparation error,16886783
2,6,22.1,Inappropriate schedule of product administration,16886783
0,6,22.1,Therapeutic product effect incomplete,16886792
0,6,22.1,Fatigue,16886822
1,6,22.1,Constipation,16886822
2,6,22.1,Cystitis,16886822
3,1,22.1,Vomiting,16886822
4,6,22.1,Off label use,16886822
5,6,22.1,Red blood cell count decreased,16886822
6,6,22.1,Incorrect dose administered,16886822
7,5,22.1,Death,16886822
8,6,22.1,Platelet count decreased,16886822
9,6,22.1,Dyspnoea,16886822
10,6,22.1,Somnolence,16886822
11,6,22.1,Chest pain,16886822
0,5,22.1,Death,16886824
0,1,22.1,Injection site pain,16886825
0,1,22.1,Ileus,16886829
0,3,22.1,Muscular weakness,16886830
0,6,22.1,Cerebral infarction,16886843
1,1,22.1,Cholangitis sclerosing,16886843
2,2,22.1,Lung disorder,16886843
0,6,22.1,Renal disorder,16886844
1,6,22.1,Skin reaction,16886844
0,2,22.1,Blood pressure increased,16886911
1,1,22.1,Platelet count decreased,16886911
2,6,22.1,Underdose,16886911
3,5,22.1,Death,16886911
0,2,22.1,Carbohydrate antigen 125 increased,16886916
1,3,22.1,Pulmonary oedema,16886916
2,1,22.1,Fatigue,16886916
3,6,22.1,Haemorrhage,16886916
4,1,22.1,Decreased appetite,16886916
5,6,22.1,Constipation,16886916
6,6,22.1,Cardiac disorder,16886916
7,6,22.1,Cardiac stress test abnormal,16886916
8,6,22.1,Heart rate increased,16886916
9,6,22.1,Laboratory test abnormal,16886916
10,1,22.1,Oesophageal candidiasis,16886916
11,1,22.1,Oesophageal ulcer,16886916
12,1,22.1,Platelet count decreased,16886916
13,6,22.1,Electrocardiogram abnormal,16886916
14,6,22.1,Red blood cell count decreased,16886916
15,6,22.1,Palpitations,16886916
16,3,22.1,Dyspnoea,16886916
17,1,22.1,Neutrophil count decreased,16886916
18,6,22.1,Neuropathy peripheral,16886916
19,6,22.1,Myocardial infarction,16886916
20,6,22.1,Blood pressure decreased,16886916
21,6,22.1,White blood cell count decreased,16886916
22,3,22.1,Weight decreased,16886916
23,6,22.1,Carbohydrate antigen 125,16886916
0,3,22.1,Pneumonia,16886924
0,6,22.1,Platelet count decreased,16886935
1,6,22.1,Neoplasm progression,16886935
0,6,22.1,Red blood cell count decreased,16886938
1,6,22.1,Mean platelet volume decreased,16886938
2,6,22.1,Mean cell volume increased,16886938
3,6,22.1,Unevaluable event,16886938
4,2,22.1,Brain tumour operation,16886938
5,6,22.1,Blood pressure increased,16886938
6,6,22.1,Mean cell haemoglobin increased,16886938
7,6,22.1,Blood alkaline phosphatase increased,16886938
0,3,22.1,Recurrent cancer,16886940
1,6,22.1,Anaemia,16886940
2,6,22.1,Oedema peripheral,16886940
3,6,22.1,Product dose omission,16886940
4,3,22.1,Vomiting,16886940
5,6,22.1,Drug ineffective,16886940
6,6,22.1,White blood cell disorder,16886940
7,6,22.1,Tumour marker increased,16886940
8,3,22.1,Nausea,16886940
9,6,22.1,Fatigue,16886940
10,6,22.1,Intra-abdominal fluid collection,16886940
0,5,22.1,Death,16886941
1,6,22.1,Hospitalisation,16886941
2,6,22.1,Abdominal discomfort,16886941
3,6,22.1,Vomiting,16886941
0,3,22.1,Fatigue,16886954
1,6,22.1,Cough,16886954
2,6,22.1,White blood cell count increased,16886954
3,6,22.1,Influenza like illness,16886954
4,6,22.1,Product use complaint,16886954
5,6,22.1,Malignant neoplasm progression,16886954
6,6,22.1,Oropharyngeal pain,16886954
7,3,22.1,Neutrophil count increased,16886954
8,6,22.1,Dizziness,16886954
9,6,22.1,Dyspnoea,16886954
10,6,22.1,Product physical issue,16886954
11,6,22.1,Gastrointestinal disorder,16886954
12,6,22.1,Myalgia,16886954
13,6,22.1,Hypoaesthesia,16886954
14,3,22.1,Constipation,16886954
15,6,22.1,Pain,16886954
16,6,22.1,Dental caries,16886954
17,3,22.1,Back pain,16886954
18,3,22.1,Dysgeusia,16886954
19,3,22.1,Insomnia,16886954
20,3,22.1,Haemoglobin decreased,16886954
21,6,22.1,Headache,16886954
22,6,22.1,Malaise,16886954
23,3,22.1,Carbohydrate antigen 125 increased,16886954
24,3,22.1,Dry mouth,16886954
25,6,22.1,Decreased appetite,16886954
0,3,22.1,Thrombocytopenia,16886963
0,5,22.1,Malignant neoplasm progression,16886966
1,6,22.1,Anaemia,16886966
2,6,22.1,Blood creatinine increased,16886966
0,3,22.1,Malignant neoplasm progression,16886967
0,1,22.1,Acute respiratory failure,16886972
1,1,22.1,Bronchospasm,16886972
0,3,22.1,Prostatic specific antigen increased,16886983
1,6,22.1,Metastases to bone,16886983
0,3,22.1,Fatigue,16887006
1,3,22.1,Product dose omission,16887006
2,1,22.1,Peripheral swelling,16887006
3,6,22.1,Ovarian cancer recurrent,16887006
4,3,22.1,Asthenia,16887006
0,3,22.1,C-reactive protein increased,16887022
0,3,22.1,Drug resistance,16887050
1,3,22.1,Hydrothorax,16887050
0,4,22.1,Nephropathy toxic,16887058
1,6,22.1,Off label use,16887058
0,6,22.1,Delirium,16887083
0,1,22.1,Sepsis,16887103
0,6,22.1,Product dose omission,16887146
1,6,22.1,No adverse event,16887146
2,6,22.1,Inappropriate schedule of product administration,16887146
0,3,22.1,Autoimmune myocarditis,16887153
0,6,22.1,Vomiting,16887176
1,3,22.1,Prostatic specific antigen abnormal,16887176
2,,22.1,Intercepted product preparation error,16887176
3,6,22.1,Drug ineffective,16887176
4,3,22.1,Constipation,16887176
0,5,22.1,Death,16887179
0,,22.1,Product packaging quantity issue,16887186
1,,22.1,Intercepted product preparation error,16887186
2,,22.1,Product physical consistency issue,16887186
0,,22.1,Product preparation issue,16887187
0,6,22.1,Muscular weakness,16887202
0,6,22.1,Abdominal pain,16887209
0,6,22.1,Product dose omission,16887211
1,6,22.1,Haematuria,16887211
0,5,22.1,Pneumonia aspiration,16887261
1,2,22.1,Liver disorder,16887261
2,6,22.1,Fistula,16887261
0,5,22.1,Death,16887299
0,1,22.1,Lower respiratory tract infection,16887306
0,6,22.1,Pneumonia,16887341
1,6,22.1,Myocardial infarction,16887341
2,1,22.1,Blood urine present,16887341
3,6,22.1,Product dose omission,16887341
0,3,22.1,Lower respiratory tract infection,16887368
0,6,22.1,Hypertension,16887377
1,6,22.1,General physical health deterioration,16887377
0,3,22.1,Dysuria,16887378
1,3,22.1,Urinary retention,16887378
0,2,22.1,Hot flush,16887379
0,1,22.1,Injection site pain,16887380
1,1,22.1,Alopecia,16887380
0,6,22.1,Chest pain,16887381
1,6,22.1,Arterial stiffness,16887381
0,6,22.1,Urinary incontinence,16887382
1,6,22.1,Micturition urgency,16887382
2,6,22.1,Injection site bruising,16887382
0,3,22.1,Gait disturbance,16887384
1,3,22.1,Hot flush,16887384
2,6,22.1,Urinary tract infection,16887384
3,3,22.1,Joint instability,16887384
0,6,22.1,Colitis,16887409
1,6,22.1,Weight decreased,16887409
0,2,22.1,Leukopenia,16887424
1,2,22.1,Neutropenia,16887424
0,6,22.1,Adrenal insufficiency,16887427
1,6,22.1,Gastritis,16887427
2,6,22.1,General physical health deterioration,16887427
3,6,22.1,Weight decreased,16887427
0,6,22.1,Decreased appetite,16887474
1,6,22.1,Pyrexia,16887474
2,3,22.1,Dyspnoea,16887474
3,3,22.1,General physical health deterioration,16887474
4,3,22.1,Cough,16887474
5,3,22.1,Pneumonia,16887474
0,5,22.1,Death,16887496
1,6,22.1,Nausea,16887496
2,5,22.1,Breast cancer metastatic,16887496
3,5,22.1,Malignant neoplasm progression,16887496
0,1,22.1,Alanine aminotransferase increased,16887500
0,4,22.1,Cataract,16887519
1,4,22.1,Condition aggravated,16887519
2,4,22.1,Corneal disorder,16887519
0,6,22.1,Neutropenia,16887523
1,1,22.1,Febrile neutropenia,16887523
2,3,22.1,Thrombocytopenia,16887523
0,1,22.1,Ileus,16887526
1,1,22.1,Pyrexia,16887526
0,5,22.1,Liver abscess,16887529
1,2,22.1,Confusional state,16887529
2,5,22.1,Abdominal abscess,16887529
3,6,22.1,Adrenal insufficiency,16887529
4,5,22.1,Abdominal pain lower,16887529
5,5,22.1,Intestinal perforation,16887529
6,5,22.1,Bowel movement irregularity,16887529
7,5,22.1,Abdominal mass,16887529
0,6,22.1,Disease recurrence,16887538
0,2,22.1,Pain in extremity,16887547
1,2,22.1,Dyspnoea,16887547
2,2,22.1,Myocarditis,16887547
3,6,22.1,Ejection fraction decreased,16887547
0,1,22.1,Hepatic function abnormal,16887562
0,6,22.1,Bone marrow toxicity,16887563
0,6,22.1,Sensory loss,16887572
1,6,22.1,Tumour compression,16887572
0,5,22.1,Breast cancer,16887578
0,5,22.1,Death,16887584
1,6,22.1,Intentional product misuse,16887584
0,6,22.1,Malignant neoplasm progression,16887585
1,6,22.1,Intentional product use issue,16887585
0,5,22.1,Malignant neoplasm progression,16887588
1,5,22.1,Liver disorder,16887588
0,6,22.1,Renal impairment,16887589
1,6,22.1,Bone marrow failure,16887589
0,6,22.1,Immunodeficiency,16887594
0,5,22.1,Death,16887604
0,2,22.1,Bone marrow failure,16887611
0,6,22.1,Cataract,16887618
1,6,22.1,Hypertension,16887618
2,6,22.1,Proteinuria,16887618
0,5,22.1,Death,16887638
1,6,22.1,Intentional product use issue,16887638
0,6,22.1,Pancreatitis,16887661
0,1,22.1,Anaphylactic shock,16887663
0,2,22.1,Myalgia,16887674
1,6,22.1,Polyarthritis,16887674
2,6,22.1,Polymyalgia rheumatica,16887674
3,2,22.1,Arthralgia,16887674
4,2,22.1,Osteoarthritis,16887674
0,6,22.1,Contusion,16887677
1,6,22.1,Haemorrhage,16887677
2,6,22.1,Thrombocytopenia,16887677
3,3,22.1,Impaired healing,16887677
0,2,22.1,Cardiac valve sclerosis,16887714
1,3,22.1,Hypertensive crisis,16887714
2,1,22.1,Rash,16887714
3,2,22.1,Tricuspid valve incompetence,16887714
4,1,22.1,Diastolic dysfunction,16887714
5,1,22.1,Vomiting,16887714
6,1,22.1,Nausea,16887714
7,6,22.1,Atrioventricular block first degree,16887714
8,1,22.1,Diarrhoea,16887714
9,2,22.1,Mitral valve incompetence,16887714
10,6,22.1,Sinus arrhythmia,16887714
11,1,22.1,Rotavirus infection,16887714
12,1,22.1,Pyrexia,16887714
13,1,22.1,Atrial fibrillation,16887714
14,1,22.1,Tachycardia,16887714
15,6,22.1,Supraventricular tachyarrhythmia,16887714
0,1,22.1,Dyspnoea at rest,16887721
1,1,22.1,Burning sensation,16887721
2,1,22.1,Flushing,16887721
0,6,22.1,Depressed mood,16887725
1,6,22.1,Depression,16887725
2,6,22.1,Weight decreased,16887725
3,6,22.1,Breast cancer,16887725
4,6,22.1,Electrocardiogram QT prolonged,16887725
5,6,22.1,Toxicity to various agents,16887725
6,6,22.1,Chest pain,16887725
7,6,22.1,CYP3A4 polymorphism,16887725
8,6,22.1,Pain,16887725
9,6,22.1,Dyspnoea,16887725
10,6,22.1,Malignant neoplasm progression,16887725
11,6,22.1,Metastases to liver,16887725
12,6,22.1,Intentional dose omission,16887725
13,6,22.1,Hyperbilirubinaemia,16887725
14,6,22.1,Decreased appetite,16887725
15,6,22.1,Nausea,16887725
16,6,22.1,Pleural disorder,16887725
0,6,22.1,Fracture,16887742
0,5,22.1,Death,16887757
0,2,22.1,Drug-induced liver injury,16887764
0,6,22.1,Fatigue,16887784
1,6,22.1,Disease progression,16887784
2,6,22.1,Metastases to lung,16887784
3,6,22.1,Intestinal fistula,16887784
4,6,22.1,Drug hypersensitivity,16887784
5,1,22.1,Transaminases increased,16887784
6,1,22.1,Haemoptysis,16887784
7,6,22.1,Pancytopenia,16887784
8,6,22.1,Eyelid ptosis,16887784
9,6,22.1,Pelvic neoplasm,16887784
10,6,22.1,Horner^s syndrome,16887784
11,1,22.1,Herpes zoster,16887784
0,3,22.1,Postoperative wound complication,16887785
1,3,22.1,Hyperhidrosis,16887785
2,3,22.1,Toxicity to various agents,16887785
3,3,22.1,Breast cancer recurrent,16887785
4,3,22.1,Malignant neoplasm progression,16887785
5,3,22.1,Rheumatoid arthritis,16887785
0,6,22.1,Burning sensation,16887788
1,6,22.1,Mobility decreased,16887788
2,6,22.1,Arthralgia,16887788
0,3,22.1,Malignant neoplasm progression,16887795
1,3,22.1,Toxicity to various agents,16887795
2,3,22.1,Breast cancer recurrent,16887795
3,3,22.1,Hyperhidrosis,16887795
4,3,22.1,Rheumatoid arthritis,16887795
5,3,22.1,Postoperative wound complication,16887795
0,6,22.1,Acute hepatic failure,16887798
1,6,22.1,Hepatitis B reactivation,16887798
0,2,22.1,Pulmonary function test decreased,16887800
1,2,22.1,Deafness,16887800
2,2,22.1,Renal impairment,16887800
0,1,22.1,Streptococcal sepsis,16887821
1,1,22.1,Erythema,16887821
2,1,22.1,Hypotension,16887821
3,1,22.1,Off label use,16887821
4,1,22.1,Pyrexia,16887821
5,1,22.1,Drug ineffective,16887821
6,6,22.1,Treatment failure,16887821
0,2,22.1,Rash macular,16888086
1,1,22.1,Ecchymosis,16888086
2,2,22.1,Pruritus,16888086
0,6,22.1,Blood pressure increased,16888326
1,6,22.1,Pneumonitis,16888326
2,6,22.1,Dizziness,16888326
0,5,22.1,Death,16888461
0,6,22.1,Hip fracture,16888728
0,6,22.1,Intentional product use issue,16888792
1,5,22.1,Death,16888792
0,6,22.1,Skin disorder,16888811
1,6,22.1,Neuropathy peripheral,16888811
0,3,22.1,Acute myeloid leukaemia,16888850
0,5,22.1,Neurotoxicity,16888851
1,5,22.1,Aplastic anaemia,16888851
2,5,22.1,Mucosal inflammation,16888851
0,3,22.1,Enterocolitis,16888906
0,5,22.1,Malignant neoplasm progression,16888974
0,1,22.1,Lung infiltration,16888981
1,1,22.1,Dyspnoea,16888981
2,1,22.1,Oxygen saturation decreased,16888981
0,6,22.1,Device use error,16889015
0,5,22.1,Aplastic anaemia,16889050
1,5,22.1,Neurotoxicity,16889050
2,5,22.1,Mucosal inflammation,16889050
0,1,22.1,Cystitis,16889052
0,2,22.1,Alveolar proteinosis,16889056
0,6,22.1,Anaemia,16889066
1,6,22.1,Pyrexia,16889066
2,6,22.1,Leukopenia,16889066
3,6,22.1,Alopecia,16889066
4,6,22.1,Hypersensitivity,16889066
5,6,22.1,Diarrhoea,16889066
6,6,22.1,Myalgia,16889066
7,6,22.1,Neutropenia,16889066
8,6,22.1,Thrombocytopenia,16889066
9,6,22.1,Arthralgia,16889066
10,6,22.1,Neuropathy peripheral,16889066
11,6,22.1,Stomatitis,16889066
0,1,22.1,Drug-induced liver injury,16889088
0,6,22.1,Malaise,16889190
1,6,22.1,Nausea,16889190
2,6,22.1,Vomiting,16889190
3,6,22.1,Anxiety,16889190
4,6,22.1,Hospitalisation,16889190
5,3,22.1,Malignant neoplasm progression,16889190
6,6,22.1,Blood test abnormal,16889190
7,6,22.1,Anaemia,16889190
8,2,22.1,Blood pressure increased,16889190
0,2,22.1,Hepatitis acute,16889197
0,6,22.1,Fatigue,16889199
1,2,22.1,Blood magnesium decreased,16889199
2,2,22.1,Platelet count decreased,16889199
3,6,22.1,Contusion,16889199
4,6,22.1,Skin laceration,16889199
0,6,22.1,Dysuria,16889200
1,1,22.1,Insomnia,16889200
2,6,22.1,Decreased appetite,16889200
3,6,22.1,Headache,16889200
4,1,22.1,Constipation,16889200
5,3,22.1,Somnolence,16889200
6,6,22.1,Blood count abnormal,16889200
7,3,22.1,Product dose omission,16889200
8,1,22.1,Cardiac failure,16889200
9,1,22.1,Pelvic pain,16889200
10,3,22.1,Arthralgia,16889200
11,1,22.1,Blood pressure increased,16889200
12,6,22.1,Weight increased,16889200
13,6,22.1,Musculoskeletal pain,16889200
14,3,22.1,Fatigue,16889200
15,6,22.1,Off label use,16889200
0,6,22.1,Product dose omission,16889201
1,3,22.1,Carbohydrate antigen 125 increased,16889201
2,3,22.1,Gastritis,16889201
3,2,22.1,Dry skin,16889201
4,1,22.1,Nausea,16889201
5,3,22.1,Fatigue,16889201
6,2,22.1,Constipation,16889201
7,3,22.1,Insomnia,16889201
8,6,22.1,Neoplasm progression,16889201
9,1,22.1,Herpes zoster,16889201
0,3,22.1,Liver disorder,16889238
0,3,22.1,Fatigue,16889258
1,3,22.1,Asthenia,16889258
0,3,22.1,Asthenia,16889268
1,3,22.1,Dyspnoea,16889268
2,6,22.1,Product dose omission,16889268
0,6,22.1,Back pain,16889296
1,6,22.1,Pharyngeal oedema,16889296
2,6,22.1,Chills,16889296
3,6,22.1,Panic reaction,16889296
4,6,22.1,Palpitations,16889296
5,6,22.1,Anxiety,16889296
0,5,22.1,Death,16889300
1,6,22.1,Intentional product use issue,16889300
0,6,22.1,Weight decreased,16889336
1,6,22.1,Hypophagia,16889336
2,6,22.1,Pain,16889336
3,6,22.1,Neoplasm progression,16889336
0,1,22.1,Cardiac failure congestive,16889338
0,2,22.1,Bone marrow failure,16889346
0,1,22.1,Anaphylactic shock,16889363
0,3,22.1,Blood creatine increased,16889364
1,3,22.1,Dehydration,16889364
0,3,22.1,Blood creatine increased,16889365
1,3,22.1,Dehydration,16889365
0,3,22.1,Neurological symptom,16889370
1,3,22.1,Pyrexia,16889370
2,3,22.1,Asthenia,16889370
3,3,22.1,Somnolence,16889370
4,6,22.1,Underdose,16889370
5,6,22.1,Inappropriate schedule of product administration,16889370
6,3,22.1,Fatigue,16889370
7,6,22.1,Asthenia,16889370
0,2,22.1,Bone marrow failure,16889418
1,1,22.1,Nausea,16889418
2,1,22.1,Pyrexia,16889418
3,1,22.1,Vomiting,16889418
4,6,22.1,Decreased appetite,16889418
5,1,22.1,Asthenia,16889418
0,6,22.1,Malignant neoplasm progression,16889438
1,6,22.1,Drug resistance,16889438
0,6,22.1,Drug resistance,16889450
1,6,22.1,Malignant neoplasm progression,16889450
0,3,22.1,Hypoaesthesia,16889464
1,3,22.1,Peripheral swelling,16889464
2,3,22.1,Fatigue,16889464
3,3,22.1,Neoplasm progression,16889464
4,3,22.1,Back pain,16889464
5,3,22.1,Diarrhoea,16889464
6,3,22.1,Rhinorrhoea,16889464
0,5,22.1,Acute leukaemia,16889465
1,5,22.1,Death,16889465
2,5,22.1,Second primary malignancy,16889465
0,6,22.1,Metastases to central nervous system,16889479
1,6,22.1,Metastases to spinal cord,16889479
0,6,22.1,Drug resistance,16889500
0,6,22.1,Spinal disorder,16889537
1,6,22.1,Dehydration,16889537
2,3,22.1,Muscular weakness,16889537
3,3,22.1,Hypoaesthesia,16889537
4,6,22.1,Back pain,16889537
5,6,22.1,Constipation,16889537
0,3,22.1,Dementia,16889541
1,2,22.1,Neutropenia,16889541
2,2,22.1,Alopecia,16889541
0,1,22.1,Pyrexia,16889647
1,1,22.1,Neutropenia,16889647
0,6,22.1,Neoplasm progression,16889656
1,6,22.1,Fatigue,16889656
0,1,22.1,Hypothyroidism,16889667
0,6,22.1,Neoplasm progression,16889678
1,6,22.1,Febrile neutropenia,16889678
2,6,22.1,Infection,16889678
3,6,22.1,Cough,16889678
4,6,22.1,Oropharyngeal pain,16889678
0,3,22.1,Tuberculosis,16889701
0,6,22.1,Pneumonia,16889731
1,6,22.1,Acute respiratory distress syndrome,16889731
2,6,22.1,Quadriplegia,16889731
0,1,22.1,Infusion related reaction,16889734
1,1,22.1,Anaphylactic shock,16889734
2,6,22.1,Off label use,16889734
3,6,22.1,Product use in unapproved indication,16889734
0,5,22.1,Death,16889737
0,5,22.1,Death,16889746
0,6,22.1,Menopause,16889780
0,1,22.1,Palmar-plantar erythrodysaesthesia syndrome,16889783
0,3,22.1,Deafness,16889785
0,6,22.1,Nausea,16889819
0,3,22.1,Jaundice cholestatic,16889914
1,3,22.1,Cholestasis,16889914
2,3,22.1,Hypertransaminasaemia,16889914
3,3,22.1,Hyperbilirubinaemia,16889914
0,5,22.1,Enterovesical fistula,16889928
1,5,22.1,Abdominal pain,16889928
0,6,22.1,Fatigue,16889938
1,6,22.1,Gait disturbance,16889938
2,3,22.1,Nausea,16889938
3,6,22.1,Intentional product use issue,16889938
4,6,22.1,Depression,16889938
5,6,22.1,Alopecia,16889938
6,6,22.1,Weight increased,16889938
7,3,22.1,Neuropathy peripheral,16889938
8,6,22.1,Off label use,16889938
0,6,22.1,Rash,16889998
0,5,22.1,Neutropenia,16890009
1,5,22.1,Stomatitis,16890009
2,5,22.1,Oesophagitis,16890009
0,6,22.1,Asthenia,16890014
1,6,22.1,Head injury,16890014
2,6,22.1,Fall,16890014
3,1,22.1,Loss of consciousness,16890014
0,5,22.1,Death,16890051
1,1,22.1,Hypokalaemia,16890051
2,3,22.1,Decreased immune responsiveness,16890051
3,3,22.1,Gastrointestinal infection,16890051
4,6,22.1,Product prescribing error,16890051
5,6,22.1,Colorectal cancer metastatic,16890051
0,1,22.1,Anaphylactic shock,16890063
0,1,22.1,Dyspnoea,16890064
1,1,22.1,Chest pain,16890064
2,1,22.1,Oxygen saturation decreased,16890064
3,1,22.1,Hyperhidrosis,16890064
4,1,22.1,Blood pressure immeasurable,16890064
0,6,22.1,Hyperphosphataemia,16890130
1,6,22.1,Recalled product,16890130
2,6,22.1,Hypocalcaemia,16890130
3,6,22.1,Electrocardiogram QT prolonged,16890130
0,3,22.1,Drug ineffective for unapproved indication,16890158
0,1,22.1,Procedural pneumothorax,16890184
1,1,22.1,Emphysema,16890184
0,5,22.1,Diarrhoea,16890189
1,6,22.1,Haematotoxicity,16890189
2,6,22.1,Febrile neutropenia,16890189
3,6,22.1,Hypokalaemia,16890189
4,3,22.1,Neutropenic sepsis,16890189
5,6,22.1,Hepatotoxicity,16890189
6,6,22.1,Infection,16890189
0,,22.1,Death,16890190
0,6,22.1,Normal newborn,16890203
1,6,22.1,Maternal exposure during pregnancy,16890203
0,,22.1,Oral pain,16890302
1,,22.1,Headache,16890302
2,,22.1,Pain of skin,16890302
3,,22.1,Trismus,16890302
4,,22.1,Decreased appetite,16890302
0,3,22.1,Taste disorder,16890348
1,1,22.1,Dyspepsia,16890348
2,6,22.1,Discomfort,16890348
3,1,22.1,Escherichia infection,16890348
4,6,22.1,Blood iron decreased,16890348
5,3,22.1,Oesophageal pain,16890348
6,1,22.1,Delirium,16890348
0,6,22.1,Syncope,16890430
1,6,22.1,Embolism,16890430
2,6,22.1,White blood cell count decreased,16890430
3,6,22.1,Hepatotoxicity,16890430
4,6,22.1,Aspartate aminotransferase increased,16890430
5,6,22.1,Vascular access complication,16890430
6,6,22.1,Blood creatine phosphokinase increased,16890430
7,6,22.1,Hyponatraemia,16890430
8,6,22.1,Platelet count decreased,16890430
9,6,22.1,Urinary tract infection,16890430
10,6,22.1,Seizure,16890430
11,6,22.1,Cardiac failure,16890430
12,6,22.1,Left ventricular dysfunction,16890430
13,6,22.1,Intestinal obstruction,16890430
14,6,22.1,Haemorrhoids,16890430
15,6,22.1,Fatigue,16890430
16,6,22.1,Weight increased,16890430
17,6,22.1,Dysarthria,16890430
18,6,22.1,Neurotoxicity,16890430
19,6,22.1,Hypertension,16890430
20,6,22.1,Stomatitis,16890430
21,6,22.1,Hypomagnesaemia,16890430
22,6,22.1,Alanine aminotransferase increased,16890430
23,6,22.1,Dyspnoea,16890430
24,6,22.1,Obstructive airways disorder,16890430
25,6,22.1,Hypokalaemia,16890430
26,6,22.1,Haemorrhoidal haemorrhage,16890430
27,6,22.1,Blood bilirubin increased,16890430
28,6,22.1,Gamma-glutamyltransferase increased,16890430
29,6,22.1,Lymphocyte count decreased,16890430
30,6,22.1,Neutrophil count decreased,16890430
31,6,22.1,Mucosal inflammation,16890430
32,6,22.1,Febrile neutropenia,16890430
33,6,22.1,Hypocalcaemia,16890430
34,6,22.1,Anaemia,16890430
35,6,22.1,Proteinuria,16890430
36,6,22.1,Hypersensitivity,16890430
0,6,22.1,White blood cell count decreased,16890536
0,6,22.1,Drug resistance,16890555
1,6,22.1,Malignant neoplasm progression,16890555
0,6,22.1,Blood count abnormal,16890567
1,6,22.1,Skin haemorrhage,16890567
2,6,22.1,Ocular hyperaemia,16890567
3,6,22.1,Pruritus,16890567
4,6,22.1,Eye inflammation,16890567
5,6,22.1,Skin irritation,16890567
6,6,22.1,Eye pain,16890567
7,6,22.1,Blood pressure increased,16890567
8,6,22.1,Dry skin,16890567
0,6,22.1,Dysgeusia,16890581
1,6,22.1,Dyspepsia,16890581
2,6,22.1,Nausea,16890581
0,6,22.1,Laboratory test abnormal,16890667
0,6,22.1,Blood test abnormal,16890671
0,6,22.1,Nasopharyngitis,16890678
0,1,22.1,Infection,16890718
1,1,22.1,Decreased appetite,16890718
2,1,22.1,White blood cell count decreased,16890718
0,6,22.1,Nausea,16890733
1,6,22.1,Vomiting,16890733
0,1,22.1,Diarrhoea,16890739
1,1,22.1,Malaise,16890739
2,1,22.1,Platelet count decreased,16890739
3,6,22.1,Pneumonia,16890739
4,1,22.1,Dehydration,16890739
5,1,22.1,Decreased appetite,16890739
6,2,22.1,Pyrexia,16890739
0,6,22.1,Sinusitis,16890741
1,6,22.1,Nasopharyngitis,16890741
0,6,22.1,Neoplasm progression,16890753
0,6,22.1,Vertigo,16890776
1,6,22.1,Somnolence,16890776
2,3,22.1,Sinusitis,16890776
3,6,22.1,Vomiting,16890776
0,2,22.1,Diarrhoea,16890777
1,2,22.1,Alopecia,16890777
2,2,22.1,Phlebitis,16890777
3,2,22.1,Pyrexia,16890777
4,2,22.1,Dehydration,16890777
5,2,22.1,Sepsis,16890777
6,2,22.1,Pancytopenia,16890777
7,2,22.1,Mucosal inflammation,16890777
0,6,22.1,Haemorrhoids,16890786
1,6,22.1,Weight decreased,16890786
2,6,22.1,Cholecystitis infective,16890786
3,6,22.1,Nasal dryness,16890786
4,6,22.1,Musculoskeletal pain,16890786
5,6,22.1,Rhinorrhoea,16890786
6,6,22.1,Back pain,16890786
7,6,22.1,Decreased appetite,16890786
8,6,22.1,Neuropathy peripheral,16890786
9,6,22.1,Gastrointestinal infection,16890786
10,6,22.1,Diarrhoea,16890786
11,6,22.1,Dysgeusia,16890786
12,6,22.1,Swollen tongue,16890786
13,6,22.1,Scab,16890786
0,6,22.1,Gastrointestinal toxicity,16890789
0,6,22.1,Neoplasm progression,16890793
1,6,22.1,Blood creatinine abnormal,16890793
2,6,22.1,Pollakiuria,16890793
3,6,22.1,Blood urea abnormal,16890793
4,6,22.1,Nail ridging,16890793
5,6,22.1,Nail discolouration,16890793
6,6,22.1,Hair texture abnormal,16890793
0,6,22.1,Full blood count decreased,16890804
1,2,22.1,Haemoglobin decreased,16890804
2,6,22.1,Fatigue,16890804
3,6,22.1,Neoplasm progression,16890804
0,2,22.1,Aphasia,16890806
1,6,22.1,Vomiting,16890806
0,3,22.1,Madarosis,16890809
1,3,22.1,Hair texture abnormal,16890809
2,3,22.1,Alopecia,16890809
3,3,22.1,Hair colour changes,16890809
4,3,22.1,Hair disorder,16890809
0,6,22.1,Asthenia,16890810
1,6,22.1,Fatigue,16890810
0,2,22.1,Cardiac failure,16890817
0,3,22.1,Bladder cancer recurrent,16890825
0,5,22.1,Death,16890851
0,1,22.1,Pneumonia,16890863
0,6,22.1,Oral mucosal blistering,16890897
1,6,22.1,Vaginal mucosal blistering,16890897
2,6,22.1,Alopecia,16890897
0,5,22.1,Mesenteric vein thrombosis,16890935
0,3,22.1,Chemical burn,16890952
1,3,22.1,Flushing,16890952
0,5,22.1,Prostate cancer metastatic,16890956
0,6,22.1,Oropharyngeal pain,16890961
1,3,22.1,Rhabdomyolysis,16890961
2,5,22.1,Malignant neoplasm progression,16890961
3,6,22.1,Pyrexia,16890961
4,6,22.1,Myalgia,16890961
5,3,22.1,Laboratory test abnormal,16890961
0,3,22.1,Hair colour changes,16890974
1,3,22.1,Alopecia,16890974
2,3,22.1,Hair texture abnormal,16890974
3,3,22.1,Hair disorder,16890974
4,3,22.1,Madarosis,16890974
0,3,22.1,Alopecia,16890979
1,3,22.1,Hair disorder,16890979
2,3,22.1,Hair colour changes,16890979
3,3,22.1,Hair texture abnormal,16890979
0,3,22.1,Hair texture abnormal,16890983
1,3,22.1,Hair colour changes,16890983
2,3,22.1,Madarosis,16890983
3,3,22.1,Alopecia,16890983
4,3,22.1,Hair disorder,16890983
0,3,22.1,White blood cell count decreased,16890989
1,1,22.1,Weight decreased,16890989
2,6,22.1,Nasopharyngitis,16890989
3,1,22.1,Vomiting,16890989
4,6,22.1,Dyspnoea,16890989
5,1,22.1,Epistaxis,16890989
6,1,22.1,Feeding disorder,16890989
7,1,22.1,Malaise,16890989
8,1,22.1,Diarrhoea,16890989
0,3,22.1,Anxiety,16890990
1,3,22.1,Alopecia,16890990
2,3,22.1,Hair texture abnormal,16890990
3,3,22.1,Hair colour changes,16890990
4,3,22.1,Hair disorder,16890990
5,3,22.1,Madarosis,16890990
0,6,22.1,Diarrhoea,16890994
1,2,22.1,Dizziness,16890994
2,6,22.1,Oral disorder,16890994
0,2,22.1,Pneumocystis jirovecii pneumonia,16891013
0,3,22.1,Back pain,16891040
1,3,22.1,Neuropathy peripheral,16891040
2,6,22.1,Malignant neoplasm progression,16891040
3,3,22.1,Nerve compression,16891040
4,2,22.1,Constipation,16891040
5,3,22.1,Weight decreased,16891040
6,3,22.1,Arthralgia,16891040
7,3,22.1,Vertigo,16891040
8,3,22.1,Decreased appetite,16891040
9,3,22.1,Fatigue,16891040
10,3,22.1,Facial pain,16891040
11,3,22.1,Product dose omission,16891040
0,6,22.1,Drug resistance,16891074
1,6,22.1,Malignant neoplasm progression,16891074
0,6,22.1,Malignant neoplasm progression,16891075
1,6,22.1,Drug resistance,16891075
0,2,22.1,Flushing,16891082
1,2,22.1,Asthenia,16891082
2,2,22.1,Hyperhidrosis,16891082
3,2,22.1,Erythema,16891082
4,2,22.1,Vomiting,16891082
5,2,22.1,Nausea,16891082
6,2,22.1,Abdominal pain upper,16891082
0,1,22.1,Agranulocytosis,16891095
1,1,22.1,Diarrhoea,16891095
2,1,22.1,Pyrexia,16891095
0,3,22.1,Acute myeloid leukaemia,16891121
1,3,22.1,Second primary malignancy,16891121
0,3,22.1,Colorectal cancer,16891128
1,1,22.1,Palmar-plantar erythrodysaesthesia syndrome,16891128
0,2,22.1,Alopecia,16891153
1,6,22.1,Psychological trauma,16891153
2,6,22.1,Anxiety,16891153
0,6,22.1,Psychological trauma,16891174
1,3,22.1,Alopecia,16891174
0,3,22.1,Alopecia,16891179
0,6,22.1,Pain,16891180
1,6,22.1,Anxiety,16891180
2,6,22.1,Emotional distress,16891180
3,3,22.1,Alopecia,16891180
4,6,22.1,Impaired quality of life,16891180
5,6,22.1,Psychological trauma,16891180
0,1,22.1,Aortitis,16891370
1,6,22.1,Pyrexia,16891370
2,2,22.1,Vasculitis,16891370
0,1,22.1,Bone marrow toxicity,16891451
1,5,22.1,Acute leukaemia,16891451
0,6,22.1,Back pain,16891472
1,6,22.1,Nausea,16891472
2,6,22.1,Hypophagia,16891472
3,6,22.1,Flank pain,16891472
4,1,22.1,General physical health deterioration,16891472
5,6,22.1,Asthenia,16891472
6,6,22.1,Oliguria,16891472
7,6,22.1,Diarrhoea,16891472
0,1,22.1,Loss of consciousness,16891473
1,1,22.1,Infusion related reaction,16891473
0,6,22.1,General physical health deterioration,16891477
1,2,22.1,Acute kidney injury,16891477
2,1,22.1,Mucosal inflammation,16891477
3,6,22.1,Weight decreased,16891477
4,6,22.1,Off label use,16891477
0,2,22.1,Febrile neutropenia,16891515
0,6,22.1,Cholecystitis,16891524
1,6,22.1,Chest pain,16891524
2,3,22.1,Hepatic enzyme increased,16891524
3,6,22.1,Sleep disorder,16891524
4,3,22.1,Vomiting,16891524
5,6,22.1,Intervertebral disc protrusion,16891524
6,6,22.1,Dehydration,16891524
7,6,22.1,Anxiety,16891524
8,6,22.1,Feeding disorder,16891524
9,3,22.1,Flatulence,16891524
10,6,22.1,Malaise,16891524
11,3,22.1,Nausea,16891524
12,3,22.1,Diarrhoea,16891524
13,6,22.1,Abdominal pain upper,16891524
0,6,22.1,Drug resistance,16891529
1,6,22.1,Malignant neoplasm progression,16891529
0,6,22.1,Drug resistance,16891531
1,6,22.1,Malignant neoplasm progression,16891531
0,6,22.1,Metastases to central nervous system,16891532
1,6,22.1,Malignant neoplasm progression,16891532
2,6,22.1,Drug resistance,16891532
3,6,22.1,Rash,16891532
0,1,22.1,Frequent bowel movements,16891554
1,1,22.1,Petit mal epilepsy,16891554
2,1,22.1,Abdominal pain upper,16891554
3,1,22.1,Vomiting,16891554
4,6,22.1,Intentional product use issue,16891554
0,5,22.1,Drug ineffective,16891568
0,6,22.1,Contusion,16891584
1,6,22.1,Mass,16891584
2,6,22.1,Discomfort,16891584
0,6,22.1,Hot flush,16891593
1,2,22.1,Joint swelling,16891593
0,6,22.1,Prostate cancer,16891605
0,3,22.1,Prostatic specific antigen increased,16891613
0,2,22.1,Osteoarthritis,16891619
1,2,22.1,Musculoskeletal pain,16891619
0,,22.1,Device leakage,16891629
1,,22.1,Intercepted product preparation error,16891629
2,,22.1,Syringe issue,16891629
0,6,22.1,Therapeutic product effect incomplete,16891636
0,1,22.1,Febrile neutropenia,16891664
0,3,22.1,Madarosis,16891713
1,3,22.1,Alopecia,16891713
2,3,22.1,Hair texture abnormal,16891713
3,3,22.1,Hair colour changes,16891713
4,3,22.1,Hair disorder,16891713
0,3,22.1,Hair texture abnormal,16891716
1,3,22.1,Alopecia,16891716
2,3,22.1,Hair disorder,16891716
3,3,22.1,Madarosis,16891716
4,3,22.1,Hair colour changes,16891716
0,3,22.1,Hair colour changes,16891717
1,3,22.1,Madarosis,16891717
2,3,22.1,Hair texture abnormal,16891717
3,3,22.1,Alopecia,16891717
4,3,22.1,Hair disorder,16891717
0,5,22.1,Death,16891790
0,3,22.1,Nausea,16891797
1,3,22.1,Muscle discomfort,16891797
2,3,22.1,Fatigue,16891797
3,6,22.1,Off label use,16891797
4,3,22.1,Arthralgia,16891797
0,5,22.1,Diffuse alveolar damage,16891829
1,5,22.1,Condition aggravated,16891829
2,5,22.1,Interstitial lung disease,16891829
3,5,22.1,Pneumonia,16891829
4,5,22.1,Hypoxia,16891829
5,5,22.1,Dyspnoea exertional,16891829
6,5,22.1,Rales,16891829
7,5,22.1,Traumatic lung injury,16891829
0,6,22.1,Somnolence,16891906
1,6,22.1,Delirium,16891906
2,5,22.1,Cervix carcinoma,16891906
3,5,22.1,Disease progression,16891906
4,6,22.1,Dysarthria,16891906
0,5,22.1,Death,16891923
0,6,22.1,Prostatic specific antigen increased,16891969
0,5,22.1,Malignant neoplasm progression,16891974
0,6,22.1,Malaise,16892039
1,3,22.1,Constipation,16892039
2,6,22.1,Fatigue,16892039
3,6,22.1,Oropharyngeal pain,16892039
4,6,22.1,Abdominal pain upper,16892039
5,6,22.1,Flatulence,16892039
6,6,22.1,Vomiting,16892039
7,6,22.1,Nausea,16892039
8,1,22.1,Hypertension,16892039
0,6,22.1,Myalgia,16892055
1,6,22.1,Off label use,16892055
2,6,22.1,Asthenia,16892055
3,6,22.1,Amenorrhoea,16892055
4,6,22.1,Alopecia,16892055
5,6,22.1,Anaemia,16892055
0,1,22.1,Hip fracture,16892056
0,,22.1,Colorectal cancer,16892151
1,,22.1,General physical health deterioration,16892151
2,,22.1,Off label use,16892151
0,1,22.1,Drug ineffective,16892153
0,6,22.1,Underdose,16892167
1,6,22.1,Injection site extravasation,16892167
0,6,22.1,Condition aggravated,16892174
1,6,22.1,Seizure,16892174
2,6,22.1,Neoplasm progression,16892174
0,3,22.1,Ascites,16892200
1,1,22.1,Clostridium difficile infection,16892200
0,1,22.1,Ventricular fibrillation,16892237
1,1,22.1,Cardiac arrest,16892237
0,5,22.1,Death,16892267
0,5,22.1,Malignant neoplasm progression,16892273
0,5,22.1,Malignant neoplasm progression,16892276
1,3,22.1,Platelet count decreased,16892276
2,6,22.1,Feeding disorder,16892276
3,6,22.1,Subileus,16892276
4,6,22.1,Peritonitis,16892276
5,6,22.1,Hepatic atrophy,16892276
6,6,22.1,Hepatic cirrhosis,16892276
7,6,22.1,Ascites,16892276
8,3,22.1,Haemoglobin decreased,16892276
9,6,22.1,Blood creatine phosphokinase decreased,16892276
10,3,22.1,Febrile neutropenia,16892276
0,6,22.1,Abdominal discomfort,16892282
1,6,22.1,Drug resistance,16892282
2,6,22.1,Malignant neoplasm progression,16892282
0,5,22.1,Haemorrhage subcutaneous,16892381
1,5,22.1,Disseminated intravascular coagulation,16892381
0,,22.1,Surgery,16892416
1,,22.1,Off label use,16892416
0,1,22.1,Uterine haemorrhage,16892426
0,5,22.1,Pulmonary toxicity,16892436
0,5,22.1,Interstitial lung disease,16892467
1,2,22.1,Hypoxia,16892467
2,2,22.1,Radiation pneumonitis,16892467
0,3,22.1,Myocardial infarction,16892489
0,6,22.1,Adverse drug reaction,16892495
1,6,22.1,Rash,16892495
2,6,22.1,Renal failure,16892495
0,6,22.1,Hepatitis,16892497
0,,22.1,Intercepted product preparation error,16892513
1,,22.1,Product leakage,16892513
0,6,22.1,Aspartate aminotransferase increased,16892514
1,6,22.1,Off label use,16892514
0,6,22.1,Needle issue,16892535
1,6,22.1,Underdose,16892535
2,6,22.1,Product preparation issue,16892535
0,,22.1,Intercepted product preparation error,16892539
1,,22.1,Product physical consistency issue,16892539
0,6,22.1,Prostatic specific antigen increased,16892540
0,6,22.1,Dizziness,16892554
1,6,22.1,Metastases to bone,16892554
2,6,22.1,Fatigue,16892554
3,6,22.1,Osteoarthritis,16892554
0,3,22.1,Injection site induration,16892563
0,3,22.1,Prostatic specific antigen increased,16892570
0,6,22.1,Aspartate aminotransferase increased,16892574
1,1,22.1,Palmar-plantar erythrodysaesthesia syndrome,16892574
2,6,22.1,Alanine aminotransferase increased,16892574
0,1,22.1,Hypersensitivity,16892577
0,6,22.1,Off label use,16892579
1,5,22.1,Pneumonia bacterial,16892579
2,5,22.1,White blood cell count decreased,16892579
3,5,22.1,Malignant neoplasm progression,16892579
0,5,22.1,Pneumonia,16892679
1,6,22.1,Dementia,16892679
0,6,22.1,Fatigue,16892683
1,1,22.1,Thrombosis,16892683
2,2,22.1,Pain,16892683
3,6,22.1,Vomiting,16892683
4,6,22.1,Abdominal pain upper,16892683
0,6,22.1,Second primary malignancy,16892684
1,6,22.1,Adenocarcinoma gastric,16892684
0,6,22.1,Adverse event,16892701
0,3,22.1,Fatigue,16892728
0,6,22.1,Haemoglobin decreased,16892729
1,6,22.1,Prostate cancer,16892729
2,6,22.1,Hypotension,16892729
3,6,22.1,Blood glucose increased,16892729
0,6,22.1,Intestinal perforation,16892786
0,6,22.1,Cholecystitis,16892832
0,6,22.1,Drug resistance,16892941
1,3,22.1,Gastrointestinal disorder,16892941
2,6,22.1,Mood altered,16892941
3,6,22.1,Malignant neoplasm progression,16892941
0,2,22.1,Hepatic function abnormal,16892955
0,6,22.1,Cervical vertebral fracture,16892961
1,6,22.1,Fall,16892961
0,5,22.1,Death,16892975
0,1,22.1,Autoimmune haemolytic anaemia,16892977
0,1,22.1,Alanine aminotransferase increased,16892983
0,6,22.1,Dementia,16893018
1,6,22.1,Delusion,16893018
2,5,22.1,Death,16893018
3,6,22.1,Aggression,16893018
4,6,22.1,Dementia Alzheimer^s type,16893018
0,6,22.1,Restlessness,16893032
1,6,22.1,Dyspepsia,16893032
2,3,22.1,Abdominal distension,16893032
3,6,22.1,Malaise,16893032
4,3,22.1,Abdominal pain upper,16893032
0,6,22.1,Haematotoxicity,16893061
1,6,22.1,Cardiotoxicity,16893061
0,6,22.1,Pneumonia aspiration,16893072
1,3,22.1,Interstitial lung disease,16893072
0,1,22.1,Burning sensation,16893081
1,1,22.1,Flushing,16893081
2,1,22.1,Dyspnoea at rest,16893081
0,1,22.1,Leukocytosis,16893086
1,6,22.1,Thrombocytopenia,16893086
0,1,22.1,Pancreatic cyst,16893111
1,1,22.1,Pancreatitis,16893111
0,6,22.1,Off label use,16893147
1,6,22.1,Intestinal obstruction,16893147
2,5,22.1,Death,16893147
3,6,22.1,Intentional product use issue,16893147
0,5,22.1,Small intestinal haemorrhage,16893181
0,1,22.1,Altered state of consciousness,16893200
1,1,22.1,Hyperhidrosis,16893200
2,1,22.1,Dyspnoea,16893200
3,1,22.1,Dizziness,16893200
4,1,22.1,Nausea,16893200
0,3,22.1,Neuropathy peripheral,16893251
1,2,22.1,Epistaxis,16893251
2,3,22.1,Lymphoedema,16893251
3,2,22.1,Pyrexia,16893251
4,6,22.1,White blood cell count decreased,16893251
5,2,22.1,Constipation,16893251
6,3,22.1,Neutrophil count decreased,16893251
0,6,22.1,Malignant neoplasm progression,16893269
0,3,22.1,Malignant neoplasm progression,16893299
0,6,22.1,Drug resistance,16893300
1,6,22.1,Malignant neoplasm progression,16893300
0,6,22.1,Drug resistance,16893301
0,6,22.1,Drug resistance,16893363
1,6,22.1,Malignant neoplasm progression,16893363
0,3,22.1,Back pain,16893369
1,3,22.1,Diarrhoea,16893369
2,3,22.1,Fatigue,16893369
3,3,22.1,Rhinorrhoea,16893369
4,3,22.1,Peripheral swelling,16893369
5,3,22.1,Hypoaesthesia,16893369
6,3,22.1,Neoplasm progression,16893369
0,1,22.1,Hyponatraemia,16893370
1,1,22.1,Polydipsia,16893370
2,1,22.1,Flushing,16893370
0,6,22.1,Surgery,16893401
1,6,22.1,Intestinal operation,16893401
2,6,22.1,Off label use,16893401
3,6,22.1,Intestinal obstruction,16893401
4,6,22.1,Red blood cell count decreased,16893401
5,6,22.1,Platelet count decreased,16893401
6,6,22.1,Underdose,16893401
7,3,22.1,Hernia,16893401
8,6,22.1,Arthropathy,16893401
0,6,22.1,Malignant neoplasm progression,16893403
1,3,22.1,Pain,16893403
2,6,22.1,Insomnia,16893403
3,6,22.1,Flatulence,16893403
4,1,22.1,Constipation,16893403
5,6,22.1,Drug ineffective,16893403
6,3,22.1,Gastric infection,16893403
7,6,22.1,Abdominal distension,16893403
8,3,22.1,Nausea,16893403
9,2,22.1,Feeling abnormal,16893403
10,6,22.1,Blood pressure decreased,16893403
11,6,22.1,Nail disorder,16893403
12,3,22.1,Urinary tract infection,16893403
13,2,22.1,Fatigue,16893403
14,6,22.1,Device issue,16893403
15,1,22.1,Abdominal pain upper,16893403
16,1,22.1,Kidney infection,16893403
17,6,22.1,Hepatic mass,16893403
0,1,22.1,Constipation,16893404
1,6,22.1,Malignant neoplasm progression,16893404
2,3,22.1,Hypertension,16893404
3,6,22.1,Headache,16893404
4,6,22.1,Drug ineffective,16893404
0,6,22.1,Unevaluable event,16893406
1,6,22.1,Pruritus,16893406
2,6,22.1,Pyrexia,16893406
3,6,22.1,Photosensitivity reaction,16893406
4,3,22.1,White blood cell count decreased,16893406
5,6,22.1,Lacrimal disorder,16893406
6,6,22.1,Aggression,16893406
7,6,22.1,Anxiety,16893406
8,6,22.1,Hordeolum,16893406
0,6,22.1,Contusion,16893411
1,2,22.1,Vomiting,16893411
2,6,22.1,Blood pressure increased,16893411
3,1,22.1,Insomnia,16893411
4,3,22.1,Gait disturbance,16893411
5,6,22.1,Product dose omission,16893411
6,3,22.1,Brain neoplasm,16893411
7,6,22.1,White blood cell count decreased,16893411
8,6,22.1,Haemoglobin decreased,16893411
9,6,22.1,Loss of personal independence in daily activities,16893411
10,6,22.1,Oedema peripheral,16893411
11,3,22.1,Blood potassium decreased,16893411
12,3,22.1,Blindness,16893411
13,6,22.1,Product physical issue,16893411
14,6,22.1,Asthenia,16893411
15,3,22.1,Dysphagia,16893411
16,3,22.1,Confusional state,16893411
17,3,22.1,Fatigue,16893411
18,1,22.1,Nausea,16893411
19,3,22.1,Muscular weakness,16893411
20,3,22.1,Cognitive disorder,16893411
21,6,22.1,Dementia,16893411
22,1,22.1,Constipation,16893411
23,3,22.1,Fall,16893411
24,3,22.1,Amnesia,16893411
25,6,22.1,Balance disorder,16893411
0,6,22.1,Abdominal pain upper,16893413
1,3,22.1,Constipation,16893413
2,6,22.1,Rash,16893413
3,6,22.1,Eczema,16893413
4,6,22.1,Carbohydrate antigen 125 increased,16893413
5,3,22.1,Dizziness,16893413
6,3,22.1,Nausea,16893413
7,6,22.1,Abdominal pain lower,16893413
8,3,22.1,Heart rate increased,16893413
9,3,22.1,Blood pressure increased,16893413
10,6,22.1,Small intestinal obstruction,16893413
11,6,22.1,Dyspepsia,16893413
12,6,22.1,Headache,16893413
13,6,22.1,Flatulence,16893413
0,6,22.1,Gene mutation,16893517
1,6,22.1,Drug resistance,16893517
0,2,22.1,Agranulocytosis,16893528
1,2,22.1,Cellulitis,16893528
2,2,22.1,Diarrhoea,16893528
0,6,22.1,Malignant neoplasm progression,16893543
1,6,22.1,Drug ineffective,16893543
0,6,22.1,Thrombocytopenia,16893548
1,6,22.1,Contusion,16893548
0,1,22.1,Hypersensitivity,16893550
1,6,22.1,Malignant neoplasm progression,16893550
0,6,22.1,Malignant neoplasm progression,16893551
1,6,22.1,Alanine aminotransferase increased,16893551
2,6,22.1,Aspartate aminotransferase increased,16893551
0,5,22.1,Renal failure,16893606
0,3,22.1,Visual impairment,16893618
1,3,22.1,Dyspnoea,16893618
2,3,22.1,Arthralgia,16893618
0,2,22.1,Neutropenia,16893631
1,2,22.1,Leukopenia,16893631
0,5,22.1,Death,16893645
1,6,22.1,Jaundice,16893645
2,6,22.1,Hepatic enzyme increased,16893645
3,6,22.1,Infection,16893645
0,6,22.1,Pleurisy,16893654
0,4,22.1,Hepatocellular injury,16893677
0,2,22.1,Pancytopenia,16893683
1,2,22.1,Asthenia,16893683
0,1,22.1,Flushing,16893687
1,1,22.1,Burning sensation,16893687
2,1,22.1,Dyspnoea at rest,16893687
0,6,22.1,Pleurisy,16893708
0,6,22.1,Weight decreased,16893714
1,6,22.1,Toxicity to various agents,16893714
2,6,22.1,Neoplasm progression,16893714
3,6,22.1,Chest pain,16893714
4,6,22.1,CYP3A4 polymorphism,16893714
5,6,22.1,Dyspnoea,16893714
6,6,22.1,Intentional dose omission,16893714
7,6,22.1,Hyperbilirubinaemia,16893714
8,6,22.1,Depressed mood,16893714
9,6,22.1,Pain,16893714
10,6,22.1,Nausea,16893714
11,6,22.1,Pleural disorder,16893714
12,6,22.1,Electrocardiogram QT prolonged,16893714
13,6,22.1,Decreased appetite,16893714
0,5,22.1,Death,16893724
0,3,22.1,Malaise,16893727
1,3,22.1,Pain,16893727
2,5,22.1,Death,16893727
3,3,22.1,Gait inability,16893727
0,3,22.1,Dermatitis acneiform,16893790
1,5,22.1,Drug ineffective,16893790
2,3,22.1,Metastases to liver,16893790
0,5,22.1,Neoplasm progression,16893811
0,6,22.1,Breast cancer,16893824
1,6,22.1,Drug ineffective,16893824
2,6,22.1,Malignant neoplasm progression,16893824
0,6,22.1,Malignant neoplasm progression,16893875
0,2,22.1,Cerebrovascular accident,16893933
0,2,22.1,Urinary tract obstruction,16893941
1,3,22.1,Hyponatraemia,16893941
2,1,22.1,Urinary tract infection,16893941
3,1,22.1,Cystitis radiation,16893941
4,3,22.1,Tenderness,16893941
5,3,22.1,Thrombosis prophylaxis,16893941
6,3,22.1,Ovarian cancer metastatic,16893941
7,3,22.1,Acute kidney injury,16893941
8,2,22.1,Anaemia,16893941
9,1,22.1,Off label use,16893941
10,1,22.1,Cystitis haemorrhagic,16893941
11,1,22.1,Cystitis,16893941
12,6,22.1,Performance status decreased,16893941
13,3,22.1,Metastases to bladder,16893941
14,1,22.1,Haematuria,16893941
15,6,22.1,Dehydration,16893941
16,3,22.1,Discomfort,16893941
0,6,22.1,Blood creatinine increased,16893944
1,6,22.1,Malignant neoplasm progression,16893944
0,2,22.1,Dry skin,16893980
1,,22.1,Pulmonary hypertension,16893980
2,3,22.1,Malaise,16893980
3,2,22.1,Blood pressure decreased,16893980
4,1,22.1,International normalised ratio increased,16893980
5,2,22.1,Tumour haemorrhage,16893980
6,2,22.1,Melaena,16893980
7,5,22.1,Colorectal cancer recurrent,16893980
8,3,22.1,Dyspnoea,16893980
9,1,22.1,Purpura,16893980
10,,22.1,Off label use,16893980
0,1,22.1,Tenderness,16894052
1,1,22.1,Peripheral artery aneurysm,16894052
2,1,22.1,Pain in extremity,16894052
3,1,22.1,Infective aneurysm,16894052
4,1,22.1,Mass,16894052
5,1,22.1,Muscular weakness,16894052
6,1,22.1,Injury,16894052
7,1,22.1,Paraesthesia,16894052
0,3,22.1,Chemical burn,16894061
0,5,22.1,Death,16894073
0,4,22.1,Interstitial lung disease,16894107
0,2,22.1,Drug interaction,16894122
1,2,22.1,Gastric ulcer haemorrhage,16894122
0,,22.1,Pneumonia,16894130
0,1,22.1,Device related infection,16894166
0,1,22.1,Diarrhoea,16894237
1,6,22.1,Malignant neoplasm progression,16894237
2,6,22.1,Metastasis,16894237
3,1,22.1,Pruritus,16894237
4,6,22.1,Drug resistance,16894237
5,1,22.1,Localised infection,16894237
0,3,22.1,Asthenia,16894262
1,3,22.1,Disorientation,16894262
2,3,22.1,Dry mouth,16894262
3,3,22.1,Anal incontinence,16894262
4,3,22.1,Platelet count decreased,16894262
5,3,22.1,Fall,16894262
6,3,22.1,Underweight,16894262
7,3,22.1,Diarrhoea,16894262
8,3,22.1,Tremor,16894262
0,,22.1,Chest discomfort,16894264
1,,22.1,Hot flush,16894264
2,,22.1,Nausea,16894264
0,3,22.1,Cough,16894273
1,1,22.1,Respiratory tract infection,16894273
2,1,22.1,Dyspnoea,16894273
3,3,22.1,Dyspnoea,16894273
0,1,22.1,Abdominal pain upper,16894277
1,1,22.1,Depressed level of consciousness,16894277
2,1,22.1,Visual impairment,16894277
3,1,22.1,Headache,16894277
0,5,22.1,Death,16894279
0,5,22.1,Lower respiratory tract infection,16894294
1,6,22.1,Malaise,16894294
2,5,22.1,Post procedural complication,16894294
3,3,22.1,Altered state of consciousness,16894294
4,6,22.1,Dysphagia,16894294
0,6,22.1,Neutrophil count abnormal,16894306
1,6,22.1,Blood count abnormal,16894306
2,6,22.1,Eructation,16894306
3,6,22.1,Nausea,16894306
0,6,22.1,Intentional dose omission,16894314
1,3,22.1,Fatigue,16894314
2,3,22.1,Feeling of body temperature change,16894314
3,5,22.1,Death,16894314
4,3,22.1,Infection,16894314
0,2,22.1,Interstitial lung disease,16894336
0,3,22.1,Xerosis,16894350
1,3,22.1,Acne,16894350
0,,22.1,Disease progression,16894357
0,3,22.1,Contusion,16894369
1,3,22.1,Skin discolouration,16894369
0,6,22.1,Metastasis,16894371
1,6,22.1,Drug resistance,16894371
2,6,22.1,Malignant neoplasm progression,16894371
0,5,22.1,Interstitial lung disease,16894373
1,6,22.1,Metastases to lung,16894373
2,6,22.1,Pleural effusion,16894373
3,3,22.1,Pneumonia,16894373
4,3,22.1,Pulmonary mycosis,16894373
0,1,22.1,Vaginal haemorrhage,16894375
1,6,22.1,Disease progression,16894375
0,,22.1,Dehydration,16894376
1,,22.1,Diarrhoea,16894376
0,1,22.1,Neoplasm progression,16894390
0,6,22.1,Malaise,16894400
0,6,22.1,White blood cell count decreased,16894455
0,1,22.1,Nausea,16894457
1,1,22.1,Fatigue,16894457
0,1,22.1,Diarrhoea,16894488
1,1,22.1,Vomiting,16894488
2,3,22.1,Nausea,16894488
3,1,22.1,Blood phosphorus decreased,16894488
4,3,22.1,Decreased appetite,16894488
0,1,22.1,Hypokalaemia,16894492
1,1,22.1,Urinary tract infection,16894492
0,3,22.1,Hemiparesis,16894497
1,3,22.1,Thrombotic stroke,16894497
0,3,22.1,Parkinson^s disease,16894521
0,5,22.1,Death,16894527
0,6,22.1,Neoplasm progression,16894538
0,6,22.1,Blood count abnormal,16894543
1,6,22.1,Fatigue,16894543
2,6,22.1,Dyspnoea,16894543
0,6,22.1,Allergic reaction to excipient,16894564
1,6,22.1,Rash,16894564
2,6,22.1,Stomatitis,16894564
0,6,22.1,Fatigue,16894565
1,6,22.1,Alopecia,16894565
2,6,22.1,Decreased appetite,16894565
3,6,22.1,Pain in extremity,16894565
4,6,22.1,Constipation,16894565
0,6,22.1,Nausea,16894580
1,6,22.1,Fatigue,16894580
2,6,22.1,Alopecia,16894580
3,6,22.1,Vomiting,16894580
4,6,22.1,Neutrophil count decreased,16894580
5,6,22.1,Abdominal pain,16894580
0,5,22.1,Death,16894625
1,1,22.1,Contusion,16894625
2,1,22.1,Abdominal pain lower,16894625
0,6,22.1,Fatigue,16894661
0,,22.1,Disease progression,16894735
0,,22.1,Death,16894740
0,6,22.1,Pneumonia,16894742
1,6,22.1,Urinary tract infection,16894742
2,6,22.1,Ileus,16894742
0,,22.1,Disease progression,16894744
0,,22.1,Therapy cessation,16894755
1,,22.1,Laboratory test abnormal,16894755
0,3,22.1,Periorbital oedema,16894858
0,5,22.1,Hepatotoxicity,16894902
0,6,22.1,Drug resistance,16894920
1,6,22.1,Malignant neoplasm progression,16894920
0,6,22.1,Malignant neoplasm progression,16894921
1,6,22.1,Anaemia,16894921
0,3,22.1,Radiation pneumonitis,16894922
0,6,22.1,Drug resistance,16894933
1,6,22.1,Malignant neoplasm progression,16894933
0,5,22.1,Pneumonia,16894934
0,5,22.1,Febrile neutropenia,16894994
0,5,22.1,Liver abscess,16895054
1,5,22.1,Disseminated intravascular coagulation,16895054
0,6,22.1,Cytopenia,16895096
1,6,22.1,Product use in unapproved indication,16895096
0,5,22.1,Death,16895097
0,6,22.1,Cytopenia,16895210
1,6,22.1,Product use in unapproved indication,16895210
0,4,22.1,Extradural haematoma,16895218
1,4,22.1,Fall,16895218
0,,22.1,Gastrointestinal haemorrhage,16895261
0,,22.1,Hernia,16895319
0,6,22.1,Pain,16895322
1,6,22.1,Condition aggravated,16895322
2,6,22.1,Bone pain,16895322
0,1,22.1,Blood culture positive,16895330
0,,22.1,Dermatitis acneiform,16895373
0,,22.1,White blood cell count decreased,16895385
0,,22.1,Hip fracture,16895396
1,,22.1,Fall,16895396
0,6,22.1,Haematemesis,16895399
1,3,22.1,Sleep disorder,16895399
2,6,22.1,Fall,16895399
3,6,22.1,Oropharyngeal discomfort,16895399
4,6,22.1,Monoplegia,16895399
5,3,22.1,Nocturia,16895399
6,6,22.1,Motion sickness,16895399
7,1,22.1,Nausea,16895399
8,1,22.1,Vomiting,16895399
9,6,22.1,Haemoglobin decreased,16895399
10,1,22.1,Constipation,16895399
11,6,22.1,Breast mass,16895399
12,6,22.1,Sinus operation,16895399
13,2,22.1,Bronchitis,16895399
14,6,22.1,Off label use,16895399
15,6,22.1,Malaise,16895399
16,1,22.1,Retching,16895399
0,2,22.1,Liver disorder,16895407
0,1,22.1,Speech disorder,16895408
1,1,22.1,Paronychia,16895408
2,6,22.1,Weight gain poor,16895408
3,6,22.1,Wrong technique in product usage process,16895408
4,6,22.1,Asthenia,16895408
5,6,22.1,Somnolence,16895408
6,2,22.1,Stomatitis,16895408
